DJIA 17,137.84 -34.84 -0.20%
NASDAQ 4,523.89 -3.80 -0.08%
S&P 500 1,990.43 -3.86 -0.19%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog

Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise?

Bulls Go Down Swinging, Refusing To Give Up Much Ground

3 Stocks Underperforming Today In The Drugs Industry

3 Reasons McKesson Corporation's Stock Could Rise

McKesson Corporation's stock continues to soar. Here's why the momentum just might keep going.

Jim Cramer Answers Twitter (TWTR) Questions on Alibaba IPO, Yahoo! (YHOO), Apple (AAPL) and More

S&P 500 Movers: GILD, TAP

Why Is Gilead Sciences, Inc. Stock Offering This Drug for Cheap?

Gilead Sciences will collect royalties on generic Sovaldi beginning as early as next year, even as it launches its next generation hepatitis C drug here in the United States.

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

See More Articles...